Prognostic Value of Inflammatory Markers in HBV-Related HCC After Hepatectomy Based on a Clinical Database

Objective Hepatitis B virus (HBV) remains an important risk factor for hepatocellular carcinoma (HCC), and inflammation plays an essential role in tumor development. This study aimed to investigate the impact of inflammatory markers in the postoperative outcomes of patients with HBV-related HCC, pro...

Full description

Saved in:
Bibliographic Details
Main Authors: Tao Zhou, Jiongze Fang, Jing Huang, Xi Yu, Yuying Shan, Shengdong Wu, Shuqi Mao, Caide Lu
Format: Article
Language:English
Published: Taylor & Francis Group 2025-12-01
Series:Journal of Investigative Surgery
Subjects:
Online Access:https://www.tandfonline.com/doi/10.1080/08941939.2025.2475020
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850189126726320128
author Tao Zhou
Jiongze Fang
Jing Huang
Xi Yu
Yuying Shan
Shengdong Wu
Shuqi Mao
Caide Lu
author_facet Tao Zhou
Jiongze Fang
Jing Huang
Xi Yu
Yuying Shan
Shengdong Wu
Shuqi Mao
Caide Lu
author_sort Tao Zhou
collection DOAJ
description Objective Hepatitis B virus (HBV) remains an important risk factor for hepatocellular carcinoma (HCC), and inflammation plays an essential role in tumor development. This study aimed to investigate the impact of inflammatory markers in the postoperative outcomes of patients with HBV-related HCC, providing valuable prognostic indicators after hepatectomy.Methods We retrospectively analyzed 222 patients with HBV-related HCC after surgical resection. The ROC curve was used to calculate biomarker cutoff values. The Kaplan–Meier method was used to estimate overall survival (OS) and recurrence-free survival (RFS), and univariate and multivariate analyses were used to identify the prognostic factors.Results The Kaplan–Meier analysis revealed that patients with high albumin-bilirubin (ALBI) score, aspartate aminotransferase to platelet ratio index (APRI), and monocyte to lymphocyte ratio (MLR) had worse OS, while those with high ALBI score and MLR had shorter RFS. Multivariate Cox regression analysis identified alpha-fetoprotein >400 ng/mL (hazard ratio [HR]: 2.447, 95% confidence interval [CI]: 1.273–4.706, p = 0.007), alanine aminotransferase (HR: 0.377, 95% CI: 0.171–0.834, p = 0.016), platelet to lymphocyte ratio (HR: 0.385, 95% CI: 0.196–0.755, p = 0.006), systemic inflammatory response index (HR: 1.844, 95% CI: 1.049–3.239, p = 0.033), ALBI score (HR: 1.808, 95% CI: 1.020–3.203, p = 0.043), APRI score (HR: 3.193, 95% CI: 1.662–6.137, p < 0.001), tumor diameter (HR: 1.083, 95% CI: 1.012–1.160, p = 0.022), and portal vein tumor thrombosis (PVTT) (HR: 6.083, 95% CI: 2.774–13.338, p < 0.0001) as independent predictors for OS. MLR (HR: 2.285, 95% CI: 1.290–4.048, p = 0.005) and PVTT (HR: 2.672, 95% CI: 1.280–5.579, p = 0.009) were confirmed as significant prognostic markers of RFS in patients with HBV-related HCC.Conclusions ALBI score, APRI, and MLR are effective prognostic predictors in patients with HBV-related HCC after curative resection. Close monitoring and adjuvant therapies should be considered for high-risk patients.
format Article
id doaj-art-1f484791c47d4173b9a6383e3d57ec61
institution OA Journals
issn 0894-1939
1521-0553
language English
publishDate 2025-12-01
publisher Taylor & Francis Group
record_format Article
series Journal of Investigative Surgery
spelling doaj-art-1f484791c47d4173b9a6383e3d57ec612025-08-20T02:15:41ZengTaylor & Francis GroupJournal of Investigative Surgery0894-19391521-05532025-12-0138110.1080/08941939.2025.2475020Prognostic Value of Inflammatory Markers in HBV-Related HCC After Hepatectomy Based on a Clinical DatabaseTao Zhou0Jiongze Fang1Jing Huang2Xi Yu3Yuying Shan4Shengdong Wu5Shuqi Mao6Caide Lu7Department of Hepatopancreatobiliary Surgery, The Affiliated Lihuili Hospital of Ningbo University, Ningbo, ChinaDepartment of Hepatopancreatobiliary Surgery, The Affiliated Lihuili Hospital of Ningbo University, Ningbo, ChinaDepartment of Hepatopancreatobiliary Surgery, The Affiliated Lihuili Hospital of Ningbo University, Ningbo, ChinaDepartment of Hepatopancreatobiliary Surgery, The Affiliated Lihuili Hospital of Ningbo University, Ningbo, ChinaDepartment of Hepatopancreatobiliary Surgery, The Affiliated Lihuili Hospital of Ningbo University, Ningbo, ChinaDepartment of Hepatopancreatobiliary Surgery, The Affiliated Lihuili Hospital of Ningbo University, Ningbo, ChinaDepartment of Hepatopancreatobiliary Surgery, The Affiliated Lihuili Hospital of Ningbo University, Ningbo, ChinaDepartment of Hepatopancreatobiliary Surgery, The Affiliated Lihuili Hospital of Ningbo University, Ningbo, ChinaObjective Hepatitis B virus (HBV) remains an important risk factor for hepatocellular carcinoma (HCC), and inflammation plays an essential role in tumor development. This study aimed to investigate the impact of inflammatory markers in the postoperative outcomes of patients with HBV-related HCC, providing valuable prognostic indicators after hepatectomy.Methods We retrospectively analyzed 222 patients with HBV-related HCC after surgical resection. The ROC curve was used to calculate biomarker cutoff values. The Kaplan–Meier method was used to estimate overall survival (OS) and recurrence-free survival (RFS), and univariate and multivariate analyses were used to identify the prognostic factors.Results The Kaplan–Meier analysis revealed that patients with high albumin-bilirubin (ALBI) score, aspartate aminotransferase to platelet ratio index (APRI), and monocyte to lymphocyte ratio (MLR) had worse OS, while those with high ALBI score and MLR had shorter RFS. Multivariate Cox regression analysis identified alpha-fetoprotein >400 ng/mL (hazard ratio [HR]: 2.447, 95% confidence interval [CI]: 1.273–4.706, p = 0.007), alanine aminotransferase (HR: 0.377, 95% CI: 0.171–0.834, p = 0.016), platelet to lymphocyte ratio (HR: 0.385, 95% CI: 0.196–0.755, p = 0.006), systemic inflammatory response index (HR: 1.844, 95% CI: 1.049–3.239, p = 0.033), ALBI score (HR: 1.808, 95% CI: 1.020–3.203, p = 0.043), APRI score (HR: 3.193, 95% CI: 1.662–6.137, p < 0.001), tumor diameter (HR: 1.083, 95% CI: 1.012–1.160, p = 0.022), and portal vein tumor thrombosis (PVTT) (HR: 6.083, 95% CI: 2.774–13.338, p < 0.0001) as independent predictors for OS. MLR (HR: 2.285, 95% CI: 1.290–4.048, p = 0.005) and PVTT (HR: 2.672, 95% CI: 1.280–5.579, p = 0.009) were confirmed as significant prognostic markers of RFS in patients with HBV-related HCC.Conclusions ALBI score, APRI, and MLR are effective prognostic predictors in patients with HBV-related HCC after curative resection. Close monitoring and adjuvant therapies should be considered for high-risk patients.https://www.tandfonline.com/doi/10.1080/08941939.2025.2475020Hepatocellular carcinomainflammatory markershepatitis B virussurvivalrecurrence
spellingShingle Tao Zhou
Jiongze Fang
Jing Huang
Xi Yu
Yuying Shan
Shengdong Wu
Shuqi Mao
Caide Lu
Prognostic Value of Inflammatory Markers in HBV-Related HCC After Hepatectomy Based on a Clinical Database
Journal of Investigative Surgery
Hepatocellular carcinoma
inflammatory markers
hepatitis B virus
survival
recurrence
title Prognostic Value of Inflammatory Markers in HBV-Related HCC After Hepatectomy Based on a Clinical Database
title_full Prognostic Value of Inflammatory Markers in HBV-Related HCC After Hepatectomy Based on a Clinical Database
title_fullStr Prognostic Value of Inflammatory Markers in HBV-Related HCC After Hepatectomy Based on a Clinical Database
title_full_unstemmed Prognostic Value of Inflammatory Markers in HBV-Related HCC After Hepatectomy Based on a Clinical Database
title_short Prognostic Value of Inflammatory Markers in HBV-Related HCC After Hepatectomy Based on a Clinical Database
title_sort prognostic value of inflammatory markers in hbv related hcc after hepatectomy based on a clinical database
topic Hepatocellular carcinoma
inflammatory markers
hepatitis B virus
survival
recurrence
url https://www.tandfonline.com/doi/10.1080/08941939.2025.2475020
work_keys_str_mv AT taozhou prognosticvalueofinflammatorymarkersinhbvrelatedhccafterhepatectomybasedonaclinicaldatabase
AT jiongzefang prognosticvalueofinflammatorymarkersinhbvrelatedhccafterhepatectomybasedonaclinicaldatabase
AT jinghuang prognosticvalueofinflammatorymarkersinhbvrelatedhccafterhepatectomybasedonaclinicaldatabase
AT xiyu prognosticvalueofinflammatorymarkersinhbvrelatedhccafterhepatectomybasedonaclinicaldatabase
AT yuyingshan prognosticvalueofinflammatorymarkersinhbvrelatedhccafterhepatectomybasedonaclinicaldatabase
AT shengdongwu prognosticvalueofinflammatorymarkersinhbvrelatedhccafterhepatectomybasedonaclinicaldatabase
AT shuqimao prognosticvalueofinflammatorymarkersinhbvrelatedhccafterhepatectomybasedonaclinicaldatabase
AT caidelu prognosticvalueofinflammatorymarkersinhbvrelatedhccafterhepatectomybasedonaclinicaldatabase